{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:04:00Z","timestamp":1780909440709,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.abb.2026.110875","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:08:15Z","timestamp":1779376095000},"page":"110875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting AURKA by MiR-490-3p overcomes paclitaxel resistance in oral squamous cell carcinoma via NF-\u03baB\/STAT3 signaling"],"prefix":"10.1016","volume":"782","author":[{"given":"Linfu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshi","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int. J. Oral Sci."},{"issue":"4","key":"10.1016\/j.abb.2026.110875_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041112","article-title":"Oral cavity squamous cell carcinoma: an update of the pharmacological treatment","volume":"11","author":"Imbesi Bellantoni","year":"2023","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.abb.2026.110875_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11112887","article-title":"Taxanes in the treatment of head and neck squamous cell carcinoma","volume":"11","author":"Hsieh","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to paclitaxel resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc1526","article-title":"Aurora-A - a guardian of poles","volume":"5","author":"Marumoto","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2282184","article-title":"Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA","volume":"56","author":"Chen","year":"2024","journal-title":"Ann. Med."},{"issue":"7","key":"10.1016\/j.abb.2026.110875_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jjco\/hyv058","article-title":"Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis","volume":"45","author":"Zhang","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.abb.2026.110875_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5483\/BMBRep.2022.55.2.169","article-title":"Aurora kinase A induces migration and invasion by inducing epithelial-to-mesenchymal transition in colon cancer cells","volume":"55","author":"Hong","year":"2022","journal-title":"BMB Rep."},{"issue":"5","key":"10.1016\/j.abb.2026.110875_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/etm.2025.12843","article-title":"Aurora kinase A promotes epithelial-mesenchymal transition by regulating P130 and P107 molecules in thyroid cancer cells","volume":"29","author":"Yang","year":"2025","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.abb.2026.110875_bib10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2174\/1871520620666201026155101","article-title":"The evaluation of effect of Aurora kinase inhibitor CCT137690 in melanoma and melanoma cancer stem cell","volume":"21","author":"Sogutlu","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"9","key":"10.1016\/j.abb.2026.110875_bib11","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1111\/jcmm.14538","article-title":"Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer","volume":"23","author":"Yang","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.abb.2026.110875_bib12","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.7150\/thno.97842","article-title":"Caspase-mediated AURKA cleavage at Asp(132) is essential for paclitaxel to elicit cell apoptosis","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.abb.2026.110875_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1158\/0008-5472.CAN-16-1004","article-title":"Aurora A and NF-\u03baB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-interacting protein TIFA","volume":"77","author":"Wei","year":"2017","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.abb.2026.110875_bib14","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.18632\/oncotarget.2682","article-title":"Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB\/microRNA-21\/PTEN signaling pathway","volume":"5","author":"Zhang","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.abb.2026.110875_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.molonc.2014.05.012","article-title":"AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers","volume":"8","author":"Katsha","year":"2014","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12935-025-03836-5","article-title":"AURKA promotes angiogenesis in uveal melanoma via activation of the JAK2\/STAT3\/VEGFA signaling pathway","volume":"25","author":"Ma","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.abb.2026.110875_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biom15101393","article-title":"The life of MicroRNAs: biogenesis, function and decay in cancer","volume":"15","author":"Ding","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13048-025-01770-8","article-title":"Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance","volume":"18","author":"Nayak","year":"2025","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.abb.2026.110875_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dna.2017.4095","article-title":"miR-654-5p targets GRAP to promote proliferation, metastasis, and chemoresistance of oral squamous cell carcinoma through Ras\/MAPK signaling","volume":"37","author":"Lu","year":"2018","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/21655979.2019.1710925","article-title":"MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-\u03b21","volume":"11","author":"Chen","year":"2020","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-022-00824-z","article-title":"MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin\/FAK\/Src\/ERK\/\u03b2-catenin pathway","volume":"29","author":"Jang","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.abb.2026.110875_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/ol.2020.11956","article-title":"MicroRNA-490-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells via targeting TMOD3","volume":"20","author":"Wang","year":"2020","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.abb.2026.110875_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/iub.1715","article-title":"MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma","volume":"70","author":"Ou","year":"2018","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12957-021-02226-1","article-title":"MicroRNA-490-3p inhibits migration and chemoresistance of colorectal cancer cells via targeting TNKS2","volume":"19","author":"Li","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2026.110875_bib25","first-page":"1127","article-title":"MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2","volume":"9","author":"Tian","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.abb.2026.110875_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5114\/aoms.2019.91351","article-title":"MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene (AURKA)","volume":"16","author":"Zhang","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.abb.2026.110875_bib27","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3389\/fonc.2020.00948","article-title":"Long non-coding RNA RP11-480I12.5 promotes the proliferation, migration, and invasion of breast cancer cells through the miR-490-3p-AURKA-Wnt\/\u03b2-Catenin axis","volume":"10","author":"Gao","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1186\/s12885-021-08882-6","article-title":"LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA","volume":"21","author":"Zhen","year":"2021","journal-title":"BMC Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.abb.2026.110875_bib29","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.4103\/jpbs.jpbs_593_25","article-title":"A narrative review on oral squamous cell carcinoma","volume":"17","author":"Muralidharan","year":"2025","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.abb.2026.110875_bib30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3332\/ecancer.2021.1325","article-title":"Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)","volume":"15","author":"Kashyap","year":"2021","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.abb.2026.110875_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123787","article-title":"STC1 promotes paclitaxel resistance in oral squamous cell carcinoma by inhibiting oxidative stress via activating the JAK\/STAT signaling pathway","volume":"377","author":"Wu","year":"2025","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.abb.2026.110875_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s12276-021-00635-6","article-title":"Aurora kinase A, a synthetic lethal target for precision cancer medicine","volume":"53","author":"Mou","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.abb.2026.110875_bib34","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","article-title":"Emerging roles of Aurora-A kinase in cancer therapy resistance","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.abb.2026.110875_bib35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3892\/ijo.2015.2842","article-title":"Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer","volume":"46","author":"Umene","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.abb.2026.110875_bib36","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41416-024-02649-z","article-title":"Inhibition of the AURKA\/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells","volume":"130","author":"Rio-Vilari\u00f1o","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.abb.2026.110875_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/00220345241309624","article-title":"Targeting Aurora A to overcome cisplatin resistance in head and neck cancer","volume":"104","author":"Li","year":"2025","journal-title":"J. Dent. Res."},{"issue":"4","key":"10.1016\/j.abb.2026.110875_bib38","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/0008-5472.CAN-06-2272","article-title":"Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha","volume":"67","author":"Briassouli","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1186\/s12885-019-6312-y","article-title":"Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-\u03baB signaling pathway","volume":"19","author":"Shen","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.abb.2026.110875_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbrc.2016.05.090","article-title":"miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A","volume":"475","author":"Chang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.abb.2026.110875_bib41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/leu.2016.325","article-title":"Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma","volume":"31","author":"Qin","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib42","first-page":"91","article-title":"MiRNA-621 exerts tumor suppressor function in gastric adenocarcinoma by targeting AURKA\/GSK-3\u03b2 pathway","volume":"68","author":"Han","year":"2021","journal-title":"Acta Biochim. Pol."},{"issue":"1","key":"10.1016\/j.abb.2026.110875_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2017.02.120","article-title":"miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA","volume":"486","author":"Qiao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.abb.2026.110875_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-19-0203","article-title":"Long noncoding RNA MALAT1 contributes to sorafenib resistance by targeting miR-140-5p\/Aurora-A signaling in hepatocellular carcinoma","volume":"19","author":"Fan","year":"2020","journal-title":"Mol. Cancer Therapeut."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986126001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:23:02Z","timestamp":1780906982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986126001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"alternative-id":["S0003986126001463"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2026.110875","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting AURKA by MiR-490-3p overcomes paclitaxel resistance in oral squamous cell carcinoma via NF-\u03baB\/STAT3 signaling","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2026.110875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110875"}}